Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleThe Illustrated Post

First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma

Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana and Ryohei Kobayashi
Journal of Nuclear Medicine November 2024, 65 (11) 1815; DOI: https://doi.org/10.2967/jnumed.124.268074
Harshad R. Kulkarni
1BAMF Health, Grand Rapids, Michigan;
2Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin A. Maupin
1BAMF Health, Grand Rapids, Michigan;
2Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Brennan
1BAMF Health, Grand Rapids, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Forsberg
1BAMF Health, Grand Rapids, Michigan;
2Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Rogers
1BAMF Health, Grand Rapids, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Olson
1BAMF Health, Grand Rapids, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon R. Mancini
1BAMF Health, Grand Rapids, Michigan;
2Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Chang
1BAMF Health, Grand Rapids, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sreenivasa R. Chandana
3The Cancer & Hematology Centers, Grand Rapids, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryohei Kobayashi
4Nihon Medi-Physics Co., Ltd., Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 11 1815
DOI 
https://doi.org/10.2967/jnumed.124.268074
PubMed 
39237345

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 13, 2024
  • Accepted for publication August 8, 2024
  • Published online November 1, 2024.

Article Versions

  • previous version (September 5, 2024 - 07:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: September 2024 to April 2025

AbstractFullPdf
Sep 2024017370
Oct 202404325
Nov 2024051975
Dec 2024020434
Jan 2025014060
Feb 2025013345
Mar 202508639
Apr 2025011059
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (11)
Journal of Nuclear Medicine
Vol. 65, Issue 11
November 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana, Ryohei Kobayashi
Journal of Nuclear Medicine Nov 2024, 65 (11) 1815; DOI: 10.2967/jnumed.124.268074

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana, Ryohei Kobayashi
Journal of Nuclear Medicine Nov 2024, 65 (11) 1815; DOI: 10.2967/jnumed.124.268074
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Uncommon Anomalous Biodistribution of 18F-DCFPyL Prostate-Specific Membrane Antigen: A Case Series
  • [68Ga]Ga-FAPI PET/CT Monitors Response to Receptor Activator of Nuclear Factor-κB Ligand Inhibitor in a Giant Cell Tumor of Bone: Correlation with Histopathology
  • Evaluating Bone Healing with [18F]NaF PET/CT During Bone Segment Transport in Femoral Fracture Treatment
Show more The Illustrated Post

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire